ANIX
Anixa Biosciences, Inc.Healthcare$2.58
◆ Neutral
Mkt Cap: $86.3M|Float: 31.7M|SI: 3.6%|DTC: 12.8
Data as of market close Mar 30, 2026
IV Rank
100
IV Pctl
83%
HV 20d
4007.0%
52W Range
$2-$5
ATR(14)
$0.19
Exp. Move
±59.2%
P/C Ratio
0.05
Earnings
May 28
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 18 | ±$1.53 | ±59.2% | $1.05 | $4.10 |
| 2026-07-17 | 109 | ±$2.67 | ±103.9% | $-0.10 | $5.25 |
| 2026-10-16 | 200 | ±$2.15 | ±83.5% | $0.43 | $4.73 |
Explore ANIX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.